Condition
Recurrence, Local Neoplasm
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Recruiting1
Unknown1
Active Not Recruiting1
Completed1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07198945Not ApplicableEnrolling By Invitation
Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection
NCT06441240Recruiting
Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.
NCT05121805Not ApplicableUnknown
Recurrences After Standard EMR vs Plus Thermal Ablation EMR
NCT01357772Phase 3Active Not Recruiting
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT04239365Not ApplicableCompleted
Follow-up Protocol of Colorectal Endoscopic Mucosal Resection Scars
Showing all 5 trials